SIGLEC10 and neoplasm: In addition, the high expression of CD24 in Cancer Cells affects the expression of SIGLEC10 in Dendritic Cells, Macrophages, GMP Cells, B Cells, and Mast Cells, which in turn affects immune disorders and leads to tumor immune escape responses [35].